Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Indivior Pharmaceuticals Inc (INDV)
USD40.36
+0.15 (+0.38%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
10710 Midlothian Turnpike 23235
North Chesterfield, VA, US
North Chesterfield, VA, US
CEO
Joseph J. Ciaffoni
Website
indivior.com
IPO
2014-12-29
CIK 1625297 ISIN US45579U1097
Also trades on
London Stock Exchange · INDV.L (GBp)
NASDAQ Global Select · INDV (USD)
Other OTC · INVVY (USD)
Other OTC · IZQVF (USD)
Description
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD40.36
+0.15 (+0.38%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.15
Float Shares
116.16M
Free Float %
93.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.44% | -5.74% | +25.34% | +13.39% | +27.18% | +6.69% | +237.57% | +102.33% | +254.44% | +251.19% | +259.44% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
40.36
Low
36.00
-10.8%
Consensus
44.67
+10.7%
Median
48.00
+18.9%
High
50.00
+23.9%
DCF (Unlevered)
2.77
-93.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | -1 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 7 |
40.57
+0.5%
|
| All Time | 13 |
31.92
-20.9%
|
Quality scores
Altman Z-Score
3.98
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+4.3% Q1'26: +19.2% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+10,833.3% ★ Q1'26: +81.6% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-3.8% Q1'26: -9.1% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+22.9% ★ Q1'26: +43.2% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+430.2% ★ Q1'26: +223.2% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%-3.8% ★ Q1'26: +4.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×1.15× Q1'26: 0.92× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.01B
est.
|
968.89M
est: 1.07B (-9.2%)
|
1.15B
est: 1.10B (+4.0%)
|
959.92M
est: 1.00B (-4.4%)
|
785.00M
est: 801.97M (-2.1%)
|
647.00M
est: 647.50M (-0.1%)
|
791.00M
est: 757.87M (+4.4%)
|
901.00M
est: 898.75M (+0.3%)
|
1.09B
est: 1.08B (+1.4%)
|
1.19B
est: 1.15B (+3.2%)
|
1.24B
est: 1.19B (+4.0%)
|
1.23B
1.20B – 1.25B
+3.2% YoY
|
1.28B
1.20B – 1.33B
+4.3% YoY
|
1.37B
1.36B – 1.37B
+6.7% YoY
|
1.45B
1.38B – 1.49B
+5.7% YoY
|
1.46B
1.40B – 1.51B
+1.4% YoY
|
| EBITDA |
8.04M
est.
|
149.27M
est: 8.50M (+1,655.3%)
|
436.97M
est: 8.80M (+4,865.3%)
|
310.42M
est: 8.01M (+3,776.8%)
|
230.00M
est: 6.39M (+3,498.2%)
|
-123.00M
est: 5.16M (-2,483.3%)
|
238.00M
est: 6.04M (+3,840.0%)
|
-46.00M
est: 7.16M (-742.1%)
|
-99.00M
est: 8.59M (-1,252.7%)
|
84.00M
est: 109.39M (-23.2%)
|
304.00M
est: 113.22M (+168.5%)
|
116.85M
114.07M – 118.71M
+3.2% YoY
|
121.86M
114.18M – 126.66M
+4.3% YoY
|
129.99M
129.69M – 130.29M
+6.7% YoY
|
137.39M
131.01M – 141.28M
+5.7% YoY
|
139.25M
132.79M – 143.19M
+1.4% YoY
|
| EBIT |
-16.95M
est.
|
136.45M
est: -17.93M (+860.9%)
|
193.00M
est: -18.56M (+1,140.0%)
|
295.14M
est: -16.88M (+1,848.0%)
|
202.00M
est: -13.48M (+1,598.6%)
|
-149.00M
est: -10.88M (-1,269.1%)
|
216.00M
est: -12.74M (+1,795.7%)
|
-62.00M
est: -15.11M (-310.4%)
|
-114.00M
est: -18.11M (-529.5%)
|
55.00M
est: 86.41M (-36.3%)
|
284.00M
est: 89.44M (+217.5%)
|
92.31M
90.11M – 93.77M
+3.2% YoY
|
96.26M
90.20M – 100.05M
+4.3% YoY
|
102.68M
102.44M – 102.92M
+6.7% YoY
|
108.53M
103.49M – 111.60M
+5.7% YoY
|
110.00M
104.90M – 113.11M
+1.4% YoY
|
| Net Income |
213.07M
est.
|
32.05M
est: 239.25M (-86.6%)
|
60.92M
est: 249.04M (-75.5%)
|
262.67M
est: 225.07M (+16.7%)
|
134.00M
est: 166.98M (-19.8%)
|
-148.00M
est: 21.43M (-790.7%)
|
205.00M
est: 98.62M (+107.9%)
|
-44.00M
est: 144.54M (-130.4%)
|
-129.00M
est: 184.82M (-169.8%)
|
2.00M
est: 210.17M (-99.0%)
|
210.00M
est: 296.62M (-29.2%)
|
414.47M
353.67M – 540.51M
+39.7% YoY
|
454.90M
410.17M – 564.97M
+9.8% YoY
|
517.37M
482.67M – 599.18M
+13.7% YoY
|
546.56M
513.61M – 566.68M
+5.6% YoY
|
595.20M
559.32M – 617.11M
+8.9% YoY
|
| SGA |
627.08M
est.
|
411.18M
est: 663.47M (-38.0%)
|
508.40M
est: 686.60M (-26.0%)
|
444.14M
est: 624.71M (-28.9%)
|
395.00M
est: 498.71M (-20.8%)
|
649.00M
est: 402.65M (+61.2%)
|
431.00M
est: 471.29M (-8.5%)
|
469.00M
est: 558.89M (-16.1%)
|
569.00M
est: 670.05M (-15.1%)
|
618.00M
est: 602.47M (+2.6%)
|
634.00M
est: 623.57M (+1.7%)
|
643.59M
628.26M – 653.80M
+3.2% YoY
|
671.15M
628.87M – 697.58M
+4.3% YoY
|
715.94M
714.27M – 717.62M
+6.7% YoY
|
756.67M
721.58M – 778.10M
+5.7% YoY
|
766.94M
731.37M – 788.66M
+1.4% YoY
|
| EPS |
1.60
est.
|
0.22
est: 1.80 (-87.8%)
|
0.42
est: 1.87 (-77.6%)
|
1.81
est: 1.69 (+7.0%)
|
0.95
est: 1.26 (-24.3%)
|
-1.08
est: 0.16 (-770.3%)
|
1.38
est: 0.74 (+86.1%)
|
-0.37
est: 1.09 (-134.0%)
|
0.01
est: 1.39 (-98.9%)
|
0.02
est: 1.66 (-99.1%)
|
1.68
est: 2.35 (-28.6%)
|
3.49
2.76 – 4.22
+48.5% YoY
|
3.81
3.20 – 4.41
+9.2% YoY
|
4.23
3.77 – 4.68
+10.8% YoY
|
4.27
4.01 – 4.43
+1.0% YoY
|
4.65
4.37 – 4.82
+8.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-15 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-169.75M
OE per share TTM
-1.33
Owner's Yield
-3.49%
Maintenance CapEx ratio
15.37%
Maint CapEx / Avg PPE
12.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
48
Total invested
54.88M
Insider transactions (90d)
6
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Matthew Sirovich | 11.44M | 8.40% | 3.17M | 8.26M | 3.17M | — | HC, IN | United States | 2024-02-14 | ↗ |
| 2 | Morgan Stanley | 9.74M | 7.10% | — | 13.00 | — | 13.00 | HC, CO | Delaware. | 2024-02-08 | ↗ |
| 3 | Brookfield Asset Management ULC | 9.38M | 7.00% | — | 9.38M | — | 9.38M | OO | — | 2024-10-04 | ↗ |
| 4 | Oaktree Capital Group Holdings GP, LLC | 9.38M | 7.00% | — | 9.38M | — | 9.38M | OO | — | 2024-10-04 | ↗ |
| 5 | Oaktree Capital Holdings, LLC | 9.38M | 7.00% | — | 9.38M | — | 9.38M | OO | — | 2024-10-04 | ↗ |
| 6 | Jeremy Mindich | 8.26M | 6.10% | — | 8.26M | — | — | HC, IN | United States | 2024-02-14 | ↗ |
| 7 | Scopia Capital Management LP | 8.26M | 6.10% | — | 8.26M | — | — | IA, PN | Delaware | 2024-02-14 | ↗ |
| 8 | Scopia Management, Inc. | 8.26M | 6.10% | — | 8.26M | — | — | HC, CO | New York | 2024-02-14 | ↗ |
| 9 | Morgan Stanley & Co. International plc | 8.14M | 5.90% | — | 13.00 | — | 13.00 | BD, FI, CO | Delaware. | 2024-02-08 | ↗ |
| 10 | Oaktree Fund GP I, L.P. | 8.06M | 6.00% | — | 8.06M | — | 8.06M | PN | — | 2024-10-04 | ↗ |
| 11 | Deerfield Management Company, L.P. | 7.36M | 5.80% | — | 7.36M | — | — | PN | Delaware | 2024-11-15 | ↗ |
| 12 | Deerfield Mgmt, L.P. | 7.36M | 5.80% | — | 7.36M | — | — | PN | Delaware | 2024-11-15 | ↗ |
| 13 | Deerfield Partners, L.P. | 7.36M | 5.80% | — | 7.36M | — | — | PN | Delaware | 2024-11-15 | ↗ |
| 14 | James E. Flynn | 7.36M | 5.80% | — | 7.36M | — | — | IN | Delaware | 2024-11-15 | ↗ |
| 15 | SOCIETE GENERALE S.A. | 7.03M | 5.17% | 7.03M | — | — | — | FI | Pris, France | 2024-04-09 | ↗ |
| 16 | Oaktree Value Opportunities Fund, L.P. | 5.44M | 4.10% | — | 5.44M | — | 5.44M | PN | — | 2024-10-04 | ↗ |
| 17 | Oaktree London Liquid Value Opportunities Fund (VOF), L.P. | 2.35M | 1.80% | — | 2.35M | — | 2.35M | PN | — | 2024-10-04 | ↗ |
| 18 | Oaktree Capital Management, L.P. | 1.32M | 1.00% | — | 1.32M | — | 1.32M | PN | — | 2024-10-04 | ↗ |
| 19 | Oaktree Phoenix Investment Fund, L.P. | 268.8K | 0.20% | — | 268.8K | — | 268.8K | PN | — | 2024-10-04 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
48
-208 vs prev Q
New positions
15
Closed positions
214
Increased
26
Reduced
19
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 18.23M +9.5M (+108.8%) | 654.11M +443.7M (+210.8%) | 14.58% +7.601 pp | 0.01% +0.007 pp | USD27.31 +31.4% | 5 qtrs — |
| 2 | OAKTREE CAPITAL MANAGEMENT LP | 7.11M -3.6M (-33.5%) | 255.06M -2.7M (-1.1%) | 5.69% -2.867 pp | 3.63% -0.197 pp | USD13.42 +167.4% | 8 qtrs — |
| 3 | FULLER & THALER ASSET MANAGEMENT, INC. | 6.37M +3.2M (+101.0%) | 228.61M +152.2M (+199.1%) | 5.10% +2.561 pp | 0.77% +0.513 pp | USD30.02 +19.5% | 2 qtrs — |
| 4 | VANGUARD GROUP INC | 5.47M +2.0M (+57.9%) | 196.40M +113.3M (+136.3%) | 4.38% +1.607 pp | 0.00% +0.002 pp | USD26.99 +32.9% | 11 qtrs — |
| 5 | TWO SEAS CAPITAL LP | 5.11M -5.4M (-51.4%) | 183.32M -69.9M (-27.6%) | 4.09% -4.316 pp | 3.78% -0.288 pp | USD23.25 +54.3% | 11 qtrs — |
| 6 | STATE STREET CORP | 4.66M +1.8M (+65.5%) | 167.18M +99.3M (+146.3%) | 3.73% +1.476 pp | 0.01% +0.003 pp | USD25.61 +40.1% | 3 qtrs — |
| 7 | MORGAN STANLEY | 4.38M -1.2M (-22.1%) | 157.07M +21.5M (+15.9%) | 3.50% -0.996 pp | 0.01% +0.001 pp | USD22.69 +58.1% | 11 qtrs — |
| 8 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.39M -3.6M (-51.4%) | 121.74M -46.7M (-27.7%) | 2.71% -2.875 pp | 1.55% -1.017 pp | USD10.68 +236.0% | 6 qtrs — |
| 9 | GOLDMAN SACHS GROUP INC | 3.18M -3.4M (-51.7%) | 114.02M -44.5M (-28.1%) | 2.54% -2.719 pp | 0.01% -0.005 pp | USD12.93 +177.5% | 11 qtrs — |
| 10 | CITADEL ADVISORS LLC | 3.06M +441.6K (+16.9%) | 109.86M +46.7M (+73.9%) | 2.45% +0.353 pp | 0.02% +0.007 pp | USD25.73 +39.4% | 8 qtrs — |
| 11 | ACADIAN ASSET MANAGEMENT LLC | 3.09M +201.7K (+7.0%) | 109.51M +40.5M (+58.6%) | 2.47% +0.161 pp | 0.18% +0.059 pp | USD19.22 +86.7% | 4 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.84M -18.6K (-0.7%) | 101.84M +33.0M (+47.9%) | 2.27% -0.015 pp | 0.01% +0.002 pp | USD19.27 +86.2% | 11 qtrs — |
| 13 | DIVISADERO STREET CAPITAL MANAGEMENT, LP | 2.78M -577.8K (-17.2%) | 99.92M +18.8M (+23.2%) | 2.23% -0.462 pp | 4.67% +1.136 pp | USD23.73 +51.2% | 3 qtrs — |
| 14 | MANGROVE PARTNERS | 2.75M +3.6K (+0.1%) | 98.53M +32.4M (+49.0%) | 2.20% +0.003 pp | 8.03% +3.144 pp | USD15.02 +138.9% | 6 qtrs — |
| 15 | NEWTYN MANAGEMENT, LLC | 2.53M -1.7M (-39.7%) | 90.94M -10.3M (-10.2%) | 2.03% -1.332 pp | 9.55% -2.841 pp | USD16.66 +115.4% | 6 qtrs — |
| 16 | MILLENNIUM MANAGEMENT LLC | 2.34M +27.5K (+1.2%) | 83.88M +28.2M (+50.6%) | 1.87% +0.022 pp | 0.04% +0.012 pp | USD12.96 +176.9% | 8 qtrs — |
| 17 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 2.30M +2.3M (+100.0%) | 82.69M +82.7M (+100.0%) | 1.84% +1.844 pp | 0.14% +0.138 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 18 | BARCLAYS PLC | 1.88M -252.7K (-11.9%) | 67.39M +46.6M (+224.4%) | 1.50% -0.202 pp | 0.02% +0.011 pp | USD13.94 +157.4% | 11 qtrs — |
| 19 | POINT72 ASSET MANAGEMENT, L.P. | 1.82M -1.0M (-36.4%) | 65.37M -3.6M (-5.3%) | 1.46% -0.833 pp | 0.07% -0.042 pp | USD11.99 +199.2% | 4 qtrs — |
| 20 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.71M +1.7M (+100.0%) | 61.21M +61.2M (+100.0%) | 1.36% +1.365 pp | 0.04% +0.036 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.24M +95.7K (+8.3%) | 44.62M +16.9M (+61.2%) | 0.99% +0.077 pp | 0.01% +0.003 pp | USD22.70 +58.1% | 3 qtrs — |
| 22 | GOLDENTREE ASSET MANAGEMENT LP | 1.24M -530.0K (-29.9%) | 44.46M +1.8M (+4.3%) | 0.99% -0.424 pp | 2.41% -1.113 pp | USD24.11 +48.8% | 2 qtrs — |
| 23 | SOROS FUND MANAGEMENT LLC | 1.15M -199.4K (-14.7%) | 41.42M +8.8M (+26.9%) | 0.92% -0.160 pp | 0.48% +0.015 pp | USD24.11 +48.8% | 2 qtrs — |
| 24 | DIMENSIONAL FUND ADVISORS LP | 1.12M +515.4K (+85.5%) | 40.12M +25.6M (+176.1%) | 0.89% +0.412 pp | 0.01% +0.005 pp | USD29.54 +21.5% | 2 qtrs — |
| 25 | GENDELL JEFFREY L | 1.10M +49.9K (+4.8%) | 39.34M +14.1M (+55.9%) | 0.88% +0.040 pp | 0.68% +0.219 pp | USD15.25 +135.3% | 5 qtrs — |
| 26 | NORTHERN TRUST CORP | 1.09M +72.6K (+7.2%) | 38.97M +14.5M (+59.5%) | 0.87% +0.058 pp | 0.01% +0.002 pp | USD18.56 +93.3% | 3 qtrs — |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 984.8K +92.0K (+10.3%) | 35.33M +13.8M (+64.2%) | 0.79% +0.074 pp | 0.00% +0.002 pp | USD24.87 +44.3% | 7 qtrs — |
| 28 | NUVEEN, LLC | 937.7K +78.1K (+9.1%) | 33.64M +12.9M (+62.3%) | 0.75% +0.062 pp | 0.01% +0.003 pp | USD21.20 +69.2% | 4 qtrs — |
| 29 | BANK OF AMERICA CORP /DE/ | 804.2K +475.7K (+144.8%) | 28.86M +20.9M (+264.3%) | 0.64% +0.381 pp | 0.00% +0.002 pp | USD29.17 +23.0% | 11 qtrs — |
| 30 | UBS GROUP AG | 788.6K -5.2K (-0.7%) | 28.29M +9.2M (+47.8%) | 0.63% -0.004 pp | 0.00% +0.002 pp | USD11.94 +200.5% | 11 qtrs — |
| 31 | VICTORY CAPITAL MANAGEMENT INC | 784.1K -22.1K (-2.7%) | 28.13M +8.7M (+44.7%) | 0.63% -0.018 pp | 0.02% +0.005 pp | USD24.11 +48.8% | 2 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 700.3K +350.8K (+100.4%) | 25.13M +16.7M (+198.2%) | 0.56% +0.281 pp | 0.00% +0.003 pp | USD25.85 +38.8% | 3 qtrs — |
| 33 | PRINCIPAL FINANCIAL GROUP INC | 693.3K +622.9K (+885.4%) | 24.88M +23.2M (+1,366.4%) | 0.55% +0.498 pp | 0.01% +0.012 pp | USD34.69 +3.4% | 2 qtrs — |
| 34 | FEDERATED HERMES, INC. | 683.2K +346.4K (+102.8%) | 24.51M +16.4M (+201.9%) | 0.55% +0.277 pp | 0.04% +0.027 pp | USD30.08 +19.3% | 2 qtrs — |
| 35 | MARSHALL WACE, LLP | 647.6K -243.5K (-27.3%) | 23.23M +1.8M (+8.1%) | 0.52% -0.195 pp | 0.02% -0.001 pp | USD24.11 +48.8% | 8 qtrs — |
| 36 | RUBRIC CAPITAL MANAGEMENT LP | 498.5K -632.4K (-55.9%) | 17.89M -9.4M (-34.4%) | 0.40% -0.506 pp | 0.21% -0.094 pp | USD11.63 +208.5% | 5 qtrs — |
| 37 | FMR LLC | 496.6K +427.2K (+615.1%) | 17.82M +16.1M (+964.2%) | 0.40% +0.342 pp | 0.00% +0.001 pp | USD34.23 +4.8% | 11 qtrs — |
| 38 | JEFFERIES FINANCIAL GROUP INC. | 486.8K -220.4K (-31.2%) | 17.47M +416.7K (+2.4%) | 0.39% -0.176 pp | 0.09% +0.009 pp | USD15.77 +127.5% | 11 qtrs — |
| 39 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 432.1K +432.1K (+100.0%) | 15.50M +15.5M (+100.0%) | 0.35% +0.346 pp | 0.05% +0.052 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 40 | OBERWEIS ASSET MANAGEMENT INC/ | 424.9K +424.9K (+100.0%) | 15.25M +15.2M (+100.0%) | 0.34% +0.340 pp | 0.56% +0.558 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 41 | SG AMERICAS SECURITIES, LLC | 412.2K +363.8K (+752.2%) | 14.79M +13.6M (+1,168.4%) | 0.33% +0.291 pp | 0.02% +0.015 pp | USD33.68 +6.5% | 3 qtrs — |
| 42 | ALTA FUNDAMENTAL ADVISERS LLC | 409.5K -65.5K (-13.8%) | 14.69M +3.2M (+28.3%) | 0.33% -0.052 pp | 6.62% +1.734 pp | USD16.72 +114.6% | 11 qtrs — |
| 43 | DEUTSCHE BANK AG\ | 389.1K +282.9K (+266.4%) | 13.96M +11.4M (+445.2%) | 0.31% +0.226 pp | 0.00% +0.004 pp | USD30.88 +16.2% | 10 qtrs — |
| 44 | AQR CAPITAL MANAGEMENT LLC | 382.2K +367.7K (+2,545.3%) | 13.71M +13.4M (+3,836.6%) | 0.31% +0.294 pp | 0.01% +0.007 pp | USD35.44 +1.2% | 2 qtrs — |
| 45 | PFM HEALTH SCIENCES, LP | 360.7K -200.8K (-35.8%) | 12.94M -596.7K (-4.4%) | 0.29% -0.161 pp | 1.29% +0.249 pp | USD10.28 +249.0% | 4 qtrs — |
| 46 | WELLS FARGO & COMPANY/MN | 354.0K +— (+0.0%) | 12.70M +4.2M (+48.8%) | 0.28% +0.000 pp | 0.00% +0.001 pp | USD24.11 +48.8% | 2 qtrs — |
| 47 | RUSSELL INVESTMENTS GROUP, LTD. | 346.2K -56.7K (-14.1%) | 12.39M +2.7M (+27.6%) | 0.28% -0.045 pp | 0.01% +0.003 pp | USD24.11 +48.8% | 2 qtrs — |
| 48 | KRENSAVAGE ASSET MANAGEMENT, LLC | 339.5K +— (+0.0%) | 12.18M +4.0M (+48.8%) | 0.27% +0.000 pp | 4.30% +0.815 pp | USD10.43 +244.0% | 6 qtrs — |
| 49 | HENNION & WALSH ASSET MANAGEMENT, INC. | 317.6K +96.2K (+43.4%) | 11.40M +6.1M (+113.5%) | 0.25% +0.077 pp | 0.39% +0.200 pp | USD20.40 +75.9% | 5 qtrs — |
| 50 | RHUMBLINE ADVISERS | 315.3K +144.6K (+84.7%) | 11.31M +7.2M (+174.8%) | 0.25% +0.116 pp | 0.01% +0.006 pp | USD24.43 +46.9% | 3 qtrs — |
| 51 | ROYCE & ASSOCIATES LP | 307.9K +61.3K (+24.9%) | 11.05M +5.1M (+85.8%) | 0.25% +0.049 pp | 0.11% +0.053 pp | USD26.45 +35.7% | 2 qtrs — |
| 52 | LEGAL & GENERAL GROUP PLC | 307.7K +172.1K (+127.0%) | 10.76M +8.0M (+292.9%) | 0.25% +0.138 pp | 0.00% +0.002 pp | USD26.81 +33.8% | 10 qtrs — |
| 53 | LSV ASSET MANAGEMENT | 291.1K +270.8K (+1,334.2%) | 10.45M +10.0M (+2,036.2%) | 0.23% +0.217 pp | 0.02% +0.022 pp | USD35.06 +2.3% | 2 qtrs — |
| 54 | INVESCO LTD. | 286.7K +210.2K (+274.6%) | 10.29M +8.4M (+457.4%) | 0.23% +0.168 pp | 0.00% +0.001 pp | USD32.74 +9.6% | 2 qtrs — |
| 55 | NOMURA HOLDINGS INC | 249.7K +44.0K (+21.4%) | 8.96M +4.0M (+80.7%) | 0.20% +0.035 pp | 0.01% +0.004 pp | USD18.47 +94.3% | 3 qtrs — |
| 56 | WALLEYE CAPITAL LLC | 247.4K -196.4K (-44.3%) | 8.88M -1.8M (-17.0%) | 0.20% -0.157 pp | 0.03% -0.013 pp | USD23.26 +54.3% | 3 qtrs — |
| 57 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 231.0K -3.2K (-1.4%) | 8.29M +2.6M (+46.8%) | 0.18% -0.003 pp | 0.00% +0.001 pp | USD24.11 +48.8% | 2 qtrs — |
| 58 | AMERIPRISE FINANCIAL INC | 230.2K +200.7K (+681.5%) | 8.26M +7.5M (+1,063.0%) | 0.18% +0.161 pp | 0.00% +0.002 pp | USD34.37 +4.4% | 2 qtrs — |
| 59 | DIADEMA PARTNERS LP | 220.3K +220.3K (+100.0%) | 7.90M +7.9M (+100.0%) | 0.18% +0.176 pp | 1.36% +1.362 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 60 | JPMORGAN CHASE & CO | 211.2K +3.6K (+1.7%) | 7.58M +2.6M (+51.4%) | 0.17% +0.003 pp | 0.00% +0.000 pp | USD16.02 +124.0% | 11 qtrs — |
| 61 | UBS ASSET MANAGEMENT AMERICAS INC | 197.6K -31.2K (-13.7%) | 7.09M +1.6M (+28.5%) | 0.16% -0.025 pp | 0.00% +0.000 pp | USD19.73 +81.9% | 7 qtrs — |
| 62 | SEI INVESTMENTS CO | 196.1K +13.5K (+7.4%) | 7.03M +2.6M (+59.8%) | 0.16% +0.011 pp | 0.01% +0.002 pp | USD19.24 +86.5% | 4 qtrs — |
| 63 | EAM INVESTORS, LLC | 182.5K +182.5K (+100.0%) | 6.55M +6.5M (+100.0%) | 0.15% +0.146 pp | 0.73% +0.729 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 64 | JANE STREET GROUP, LLC | 175.9K -237.0K (-57.4%) | 6.31M -3.6M (-36.6%) | 0.14% -0.190 pp | 0.00% -0.001 pp | USD23.49 +52.7% | 3 qtrs — |
| 65 | SWISS NATIONAL BANK | 172.3K -21.1K (-10.9%) | 6.18M +1.5M (+32.6%) | 0.14% -0.017 pp | 0.00% +0.001 pp | USD23.80 +50.8% | 11 qtrs — |
| 66 | D. E. SHAW & CO., INC. | 170.9K -42.4K (-19.9%) | 6.13M +989.2K (+19.2%) | 0.14% -0.034 pp | 0.00% +0.001 pp | USD19.21 +86.8% | 5 qtrs — |
| 67 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 168.5K +32.0K (+23.5%) | 6.05M +2.8M (+83.8%) | 0.13% +0.026 pp | 0.03% +0.014 pp | USD25.73 +39.4% | 3 qtrs — |
| 68 | QUANTBOT TECHNOLOGIES LP | 163.9K +36.6K (+28.8%) | 5.88M +2.8M (+91.7%) | 0.13% +0.029 pp | 0.20% +0.112 pp | USD26.74 +34.2% | 2 qtrs — |
| 69 | PDT PARTNERS, LLC | 142.8K -39.4K (-21.6%) | 5.12M +731.0K (+16.6%) | 0.11% -0.032 pp | 0.33% +0.055 pp | USD9.62 +273.0% | 6 qtrs — |
| 70 | ALLIANCEBERNSTEIN L.P. | 140.2K +11.9K (+9.3%) | 5.03M +1.9M (+62.6%) | 0.11% +0.010 pp | 0.00% +0.001 pp | USD17.33 +107.0% | 11 qtrs — |
| 71 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 136.5K +86.8K (+174.6%) | 4.90M +3.7M (+308.7%) | 0.11% +0.069 pp | 0.04% +0.026 pp | USD31.59 +13.6% | 2 qtrs — |
| 72 | MARTINGALE ASSET MANAGEMENT L P | 127.1K +31.2K (+32.5%) | 4.56M +2.2M (+97.2%) | 0.10% +0.025 pp | 0.12% +0.058 pp | USD25.59 +40.2% | 3 qtrs — |
| 73 | OSSIAM | 126.2K +126.2K (+100.0%) | 4.53M +4.5M (+100.0%) | 0.10% +0.101 pp | 0.09% +0.090 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 74 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 119.5K -13.6K (-10.2%) | 4.29M +1.1M (+33.6%) | 0.10% -0.011 pp | 0.01% +0.003 pp | USD19.52 +83.8% | 6 qtrs — |
| 75 | VERITION FUND MANAGEMENT LLC | 118.0K +118.0K (+100.0%) | 4.23M +4.2M (+100.0%) | 0.09% +0.094 pp | 0.02% +0.017 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 76 | RITHOLTZ WEALTH MANAGEMENT | 116.3K +23.4K (+25.2%) | 4.17M +1.9M (+86.4%) | 0.09% +0.019 pp | 0.08% +0.033 pp | USD26.48 +35.5% | 2 qtrs — |
| 77 | TWO SIGMA INVESTMENTS, LP | 115.0K -30.9K (-21.2%) | 4.13M +609.3K (+17.3%) | 0.09% -0.025 pp | 0.01% +0.001 pp | USD21.06 +70.4% | 8 qtrs — |
| 78 | PRICE T ROWE ASSOCIATES INC /MD/ | 114.9K +28.7K (+33.4%) | 4.12M +2.0M (+98.4%) | 0.09% +0.023 pp | 0.00% +0.000 pp | USD22.12 +62.2% | 3 qtrs — |
| 79 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 110.3K +110.3K (+100.0%) | 3.96M +4.0M (+100.0%) | 0.09% +0.088 pp | 0.00% +0.005 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 80 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 105.1K +105.1K (+100.0%) | 3.77M +3.8M (+100.0%) | 0.08% +0.084 pp | 0.19% +0.193 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 81 | FRANKLIN RESOURCES INC | 102.7K +44.6K (+76.8%) | 3.68M +2.3M (+162.9%) | 0.08% +0.036 pp | 0.00% +0.001 pp | USD29.22 +22.8% | 2 qtrs — |
| 82 | MAN GROUP PLC | 100.6K -47.7K (-32.2%) | 3.61M +34.2K (+1.0%) | 0.08% -0.038 pp | 0.01% 0.000 pp | USD24.11 +48.8% | 2 qtrs — |
| 83 | SOLEUS CAPITAL MANAGEMENT, L.P. | 100.0K -1.4M (-93.2%) | 3.59M -31.8M (-89.8%) | 0.08% -1.093 pp | 0.13% -1.647 pp | USD24.11 +48.8% | 2 qtrs — |
| 84 | STONEPINE CAPITAL MANAGEMENT, LLC | 100.0K +— (+0.0%) | 3.59M +1.2M (+48.8%) | 0.08% +0.000 pp | 2.62% +0.660 pp | USD10.67 +236.3% | 6 qtrs — |
| 85 | CLARK ESTATES INC/NY | 92.3K -61.3K (-39.9%) | 3.31M -391.6K (-10.6%) | 0.07% -0.049 pp | 0.80% -0.043 pp | USD10.21 +251.4% | 6 qtrs — |
| 86 | CITIGROUP INC | 92.0K +55.1K (+148.9%) | 3.30M +2.4M (+270.4%) | 0.07% +0.044 pp | 0.00% +0.001 pp | USD27.16 +32.1% | 11 qtrs — |
| 87 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 85.3K +85.3K (+100.0%) | 3.06M +3.1M (+100.0%) | 0.07% +0.068 pp | 0.01% +0.006 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 88 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 85.1K -9.9K (-10.4%) | 3.05M +763.0K (+33.3%) | 0.07% -0.008 pp | 0.00% +0.001 pp | USD23.36 +53.6% | 3 qtrs — |
| 89 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 83.1K +83.1K (+100.0%) | 2.98M +3.0M (+100.0%) | 0.07% +0.067 pp | 0.00% +0.001 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 90 | PANORAMIC CAPITAL, LLC | 75.0K +41.9K (+126.4%) | 2.69M +1.9M (+236.9%) | 0.06% +0.034 pp | 1.44% +1.086 pp | USD30.68 +16.9% | 2 qtrs — |
| 91 | JACKSON CREEK INVESTMENT ADVISORS LLC | 72.4K +11.5K (+18.9%) | 2.60M +1.1M (+76.9%) | 0.06% +0.009 pp | 0.77% +0.342 pp | USD25.98 +38.1% | 2 qtrs — |
| 92 | CENTERBOOK PARTNERS LP | 68.1K -41.4K (-37.8%) | 2.44M -196.4K (-7.4%) | 0.05% -0.033 pp | 0.12% -0.011 pp | USD11.13 +222.4% | 6 qtrs — |
| 93 | METLIFE INVESTMENT MANAGEMENT, LLC | 67.2K -5.7K (-7.8%) | 2.41M +654.0K (+37.2%) | 0.05% -0.005 pp | 0.01% +0.003 pp | USD14.74 +143.4% | 3 qtrs — |
| 94 | TREXQUANT INVESTMENT LP | 66.8K -45.4K (-40.4%) | 2.40M -307.6K (-11.4%) | 0.05% -0.036 pp | 0.02% -0.007 pp | USD24.11 +48.8% | 2 qtrs — |
| 95 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 63.5K +63.5K (+100.0%) | 2.28M +2.3M (+100.0%) | 0.05% +0.051 pp | 0.02% +0.024 pp | USD35.88 +0.0% | 1 qtrs NEW |
| 96 | RAYMOND JAMES FINANCIAL INC | 60.8K +12.1K (+24.7%) | 2.18M +1.0M (+85.6%) | 0.05% +0.010 pp | 0.00% +0.000 pp | USD26.18 +37.1% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 159 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco S&P SmallCap Health Care ETF PSCH | 2.16% | 3.53M | 0.29% |
| 2 | Invesco S&P SmallCap Momentum ETF XSMO | 2.05% | 62.81M | 0.36% |
| 3 | Innovator IBD 50 ETF FFTY | 1.97% | 1.76M | 0.80% |
| 4 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.57% | 7.40M | 0.35% |
| 5 | ETC 6 Meridian Small Cap Equity ETF SIXS | 1.34% | 1.42M | 0.52% |
| 6 | First Trust Small Cap BuyWrite Income ETF FTKI | 1.28% | 321.9K | 0.86% |
| 7 | Franklin Small Cap Enhanced ETF FSML | 1.17% | 1.74M | 0.45% |
| 8 | Hartford Multifactor Small Cap ETF ROSC | 1.14% | 698.0K | 0.34% |
| 9 | iShares U.S. Pharmaceuticals ETF IHE | 1.11% | 14.90M | 0.38% |
| 10 | Federated Hermes MDT Small Cap Core ETF FSCC | 1.08% | 1.78M | 0.51% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.58
Bullish
Ratio by volume
1.62
Bullish
Buys
31
Sells
12
Shares acquired
923.6K
Shares disposed
569.8K
Cash buys
8.00
Cash sales
—
Net activity
+353,789
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2028-06-02 | Barry Patrick A | Officer | — | — | Restricted Stock Units | 130,312 | 0.00 | — | 0 | D | ↗ |
| 2028-05-08 | Ciaffoni Joseph | Director / Officer | — | — | Restricted Stock Units | 422,302 | 0.00 | — | 0 | D | ↗ |
| 2028-03-07 | Preblick Ryan | Officer | — | — | Restricted Stock Units | 70,459 | 0.00 | — | 0 | D | ↗ |
| 2028-03-07 | Heidbreder Christian | Officer | — | — | Restricted Stock Units | 82,287 | 0.00 | — | 0 | D | ↗ |
| 2028-03-07 | Burris Jeffrey W | Officer | — | — | Restricted Stock Units | 71,743 | 0.00 | — | 0 | D | ↗ |
| 2028-03-07 | Anderson Woodrow D | Officer | — | — | Restricted Stock Units | 29,478 | 0.00 | — | 0 | D | ↗ |
| 2026-03-14 | Preblick Ryan | Officer | F-InKind | D | Common Stock | 2,843 | 31.11 | 88.4K | 320,751 | D | ↗ |
| 2026-03-13 | Ryan Barbara | Director | P-Purchase | A | Common Stock | 8 | 31.09 | 248.68 | 5,724 | D | ↗ |
| 2026-03-09 | Ryan Barbara | Director | P-Purchase | A | Common Stock | 31 | 32.56 | 1.0K | 5,716 | D | ↗ |
| 2026-03-06 | Kingsley Stuart A | Director | P-Purchase | A | Common Stock | 940 | 31.87 | 30.0K | 5,582 | D | ↗ |
| 2026-03-03 | Preblick Ryan | Officer | F-InKind | D | Common Stock | 87,597 | 31.98 | 2.80M | 230,343 | D | ↗ |
| 2026-03-03 | Heidbreder Christian | Officer | M-Exempt | D | Performance Stock Units | 132,565 | 0.00 | — | 0 | D | ↗ |
| 2026-03-03 | Burris Jeffrey W | Officer | M-Exempt | A | Common Stock | 79,893 | 0.00 | — | 107,550 | D | ↗ |
| 2026-03-03 | Anderson Woodrow D | Officer | M-Exempt | D | Restricted Stock Units | 5,946 | 0.00 | — | 0 | D | ↗ |
| 2026-02-10 | Preblick Ryan | Officer | A-Award | A | Common Stock | 37,358 | 0.00 | — | 317,940 | D | ↗ |
| 2026-02-10 | Heidbreder Christian | Officer | A-Award | A | Common Stock | 33,622 | 0.00 | — | 190,762 | D | ↗ |
| 2026-02-10 | Ciaffoni Joseph | Director / Officer | A-Award | A | Common Stock | 79,976 | 0.00 | — | 135,976 | D | ↗ |
| 2026-02-10 | Burris Jeffrey W | Officer | A-Award | A | Common Stock | 26,897 | 0.00 | — | 27,657 | D | ↗ |
| 2026-02-10 | Barry Patrick A | Officer | A-Award | A | Common Stock | 31,380 | 0.00 | — | 31,380 | D | ↗ |
| 2026-02-10 | Anderson Woodrow D | Officer | A-Award | A | Common Stock | 6,903 | 0.00 | — | 11,293 | D | ↗ |
| 2026-02-09 | Preblick Ryan | Officer | A-Award | A | Performance Stock Units | 113,510 | 0.00 | — | 113,510 | D | ↗ |
| 2026-02-09 | Heidbreder Christian | Officer | A-Award | A | Performance Stock Units | 132,565 | 0.00 | — | 132,565 | D | ↗ |
| 2026-02-09 | Burris Jeffrey W | Officer | A-Award | A | Performance Stock Units | 104,300 | 0.00 | — | 104,300 | D | ↗ |
| 2026-02-09 | Anderson Woodrow D | Officer | A-Award | A | Performance Stock Units | 23,975 | 0.00 | — | 23,975 | D | ↗ |
| 2026-01-26 | Wheadon David E. | Director | A-Award | A | Common Stock | 5,955 | 0.00 | — | 20,350 | D | ↗ |
| 2026-01-26 | Thompson Juliet | Director | A-Award | A | Common Stock | 3,722 | 0.00 | — | 7,572 | D | ↗ |
| 2026-01-26 | Stejbach Mark | Director | A-Award | A | Common Stock | 3,722 | 0.00 | — | 20,569 | D | ↗ |
| 2026-01-26 | Ryan Barbara | Director | A-Award | A | Common Stock | 3,722 | 0.00 | — | 5,685 | D | ↗ |
| 2026-01-26 | NINIVAGGI DANIEL A | Director | A-Award | A | Common Stock | 3,722 | 0.00 | — | 20,645 | D | ↗ |
| 2026-01-26 | Kingsley Stuart A | Director | A-Award | A | Common Stock | 3,722 | 0.00 | — | 4,642 | D | ↗ |
| 2026-01-26 | Humphreys Keith | Director | A-Award | A | Common Stock | 3,722 | 0.00 | — | 9,524 | D | ↗ |
| 2026-01-05 | Wheadon David E. | Director | P-Purchase | A | Ordinary Shares | 1,771 | 35.39 | 62.7K | 14,395 | D | ↗ |
| 2026-01-05 | Stejbach Mark | Director | P-Purchase | A | Ordinary Shares | 775 | 35.39 | 27.4K | 16,847 | D | ↗ |
| 2026-01-05 | Ryan Barbara | Director | P-Purchase | A | Ordinary Shares | 775 | 35.39 | 27.4K | 1,963 | D | ↗ |
| 2026-01-05 | NINIVAGGI DANIEL A | Director | P-Purchase | A | Ordinary Shares | 775 | 35.39 | 27.4K | 16,923 | D | ↗ |
| 2026-01-05 | Humphreys Keith | Director | P-Purchase | A | Ordinary Shares | 775 | 35.39 | 27.4K | 5,802 | D | ↗ |
| 2026-01-01 | Wheadon David E. | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 12,624 | D | ↗ |
| 2026-01-01 | Thompson Juliet | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 3,850 | D | ↗ |
| 2026-01-01 | Stejbach Mark | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 16,072 | D | ↗ |
| 2026-01-01 | Ryan Barbara | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 1,188 | D | ↗ |
| 2026-01-01 | Preblick Ryan | Officer | — | — | Ordinary Shares | 0 | 0.00 | — | 280,582 | D | ↗ |
| 2026-01-01 | NINIVAGGI DANIEL A | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 16,148 | D | ↗ |
| 2026-01-01 | Kingsley Stuart A | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 920 | D | ↗ |
| 2026-01-01 | Humphreys Keith | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 5,027 | D | ↗ |
| 2026-01-01 | Heidbreder Christian | Officer | — | — | Ordinary Shares | 0 | 0.00 | — | 157,140 | D | ↗ |
| 2026-01-01 | Ciaffoni Joseph | Director / Officer | — | — | Performance Stock Units | 1,266,903 | 0.00 | — | 0 | D | ↗ |
| 2026-01-01 | Burris Jeffrey W | Officer | — | — | Ordinary Shares | 0 | 0.00 | — | 760 | D | ↗ |
| 2026-01-01 | Anderson Woodrow D | Officer | — | — | Ordinary Shares | 0 | 0.00 | — | 4,390 | D | ↗ |
Executive team
Top executives
EBIT / Employee
275.7K
Shares Outstanding
124.77M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joe Ciaffoni Chief Executive Officer | 680.1K | — | 15.32M | — | 2.10M | 401.7K | 18.50M | 82.80% | ↗ |
| 2 | 2025 | Pat Barry Chief Commercial Officer | 408.3K | 300.0K | 3.25M | — | 840.0K | 110.0K | 4.91M | 66.20% | ↗ |
| 3 | 2025 | Christian Heidbreder Chief Scientific Officer | 652.6K | — | 2.69M | — | 783.2K | 57.1K | 4.18M | 64.31% | ↗ |
| 4 | 2025 | Richard Simkin Former Chief Commercial Officer | 325.0K | — | 2.97M | — | 448.8K | 274.9K | 4.02M | 73.90% | ↗ |
| 5 | 2025 | Ryan Preblick Chief Financial Officer | 558.8K | — | 2.30M | — | 670.6K | 59.9K | 3.59M | 64.11% | ↗ |
| 6 | 2025 | Jeff Burris Chief Legal Officer | 569.0K | — | 2.34M | — | 569.0K | 45.4K | 3.52M | 66.39% | ↗ |
| 7 | 2025 | Mark Crossley Former Chief Executive Officer | 902.3K | — | 162.5K | — | 2.05M | 66.3K | 3.19M | 5.10% | ↗ |
| 8 | 2024 | Mark Crossley Former Chief Executive Officer | 871.8K | — | 2.65M | — | 268.1K | 62.9K | 3.85M | 68.79% | ↗ |
| 9 | 2024 | Richard Simkin Former Chief Commercial Officer | 753.6K | — | 1.99M | — | 216.3K | 227.4K | 3.19M | 62.41% | ↗ |
| 10 | 2024 | Christian Heidbreder Chief Scientific Officer | 630.6K | — | 1.66M | — | 155.1K | 57.9K | 2.51M | 66.35% | ↗ |
| 11 | 2024 | Ryan Preblick Chief Financial Officer | 539.9K | — | 1.55M | — | 132.8K | 54.2K | 2.28M | 68.14% | ↗ |
| 12 | 2024 | Jeff Burris Chief Legal Officer | 500.9K | — | 1.32M | — | 102.7K | 44.9K | 1.97M | 67.08% | ↗ |
| 13 | 2023 | Mark Crossley Former Chief Executive Officer | 834.2K | — | 2.44M | — | 1.06M | 58.4K | 4.39M | 55.45% | ↗ |
| 14 | 2023 | Richard Simkin Former Chief Commercial Officer | 721.2K | — | 1.86M | — | 858.2K | 176.5K | 3.62M | 51.45% | ↗ |
| 15 | 2023 | Christian Heidbreder Chief Scientific Officer | 603.4K | — | 1.56M | — | 615.5K | 76.3K | 2.85M | 54.59% | ↗ |
| 16 | 2023 | Ryan Preblick Chief Financial Officer | 516.7K | — | 1.43M | — | 395.3K | 52.5K | 2.40M | 59.77% | ↗ |
| 17 | 2023 | Jeff Burris Chief Legal Officer | 474.8K | — | 1.23M | — | 403.5K | 98.8K | 2.20M | 55.63% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph J. Ciaffoni | Chief Executive Officer & Director | 4M | male |
| Patrick A. Barry | Chief Commercial Officer | 2M | male |
| Christian Heidbreder | Chief Scientific Officer | 1M | — |
| Ryan Preblick | Chief Financial Officer | 1M | male |
| Jeffrey W. Burris | Chief Legal Officer | 1M | male |
| Vanessa Procter | Executive Vice President of Corporate Affairs | — | female |
| Alice G. Givens | Company Secretary | — | female |
| Vishal Kalia | Chief Strategy & Operating Officer | — | male |
| Angela Colon-Mahoney | Chief Human Resources Officer | — | female |
| Hillel West | Chief Manufacturing & Supply Officer | — | male |
| Jason Thompson | Vice President of Investor Relations | — | male |
| Kevin L. Espinoza | Chief Integrity & Compliance Officer | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for INDV
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
